519 related articles for article (PubMed ID: 29225061)
1. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
Chancellor MB; Bartolone SN; Veerecke A; Lamb LE
J Urol; 2018 May; 199(5):1344-1350. PubMed ID: 29225061
[TBL] [Abstract][Full Text] [Related]
2. Development of an interstitial cystitis risk score for bladder permeability.
Lamb LE; Janicki JJ; Bartolone SN; Peters KM; Chancellor MB
PLoS One; 2017; 12(10):e0185686. PubMed ID: 29088231
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.
Blalock EM; Korrect GS; Stromberg AJ; Erickson DR
J Urol; 2012 Feb; 187(2):725-32. PubMed ID: 22177197
[TBL] [Abstract][Full Text] [Related]
4. Clustering of Patients with Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Lai HH; Thu JHL; Moh FV; Paradis A; Vetter J
J Urol; 2019 Sep; 202(3):546-551. PubMed ID: 30916629
[TBL] [Abstract][Full Text] [Related]
5. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
6. Clinical guidelines for interstitial cystitis/bladder pain syndrome.
Homma Y; Akiyama Y; Tomoe H; Furuta A; Ueda T; Maeda D; Lin AT; Kuo HC; Lee MH; Oh SJ; Kim JC; Lee KS
Int J Urol; 2020 Jul; 27(7):578-589. PubMed ID: 32291805
[TBL] [Abstract][Full Text] [Related]
7. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
[TBL] [Abstract][Full Text] [Related]
8. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
9. Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.
Lai HH; Pickersgill NA; Vetter JM
J Urol; 2020 Sep; 204(3):518-523. PubMed ID: 32223699
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
11. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
[TBL] [Abstract][Full Text] [Related]
12. Comparison of urologic and non-urologic presentation in interstitial cystitis/bladder pain syndrome patients with and without Hunner lesions.
Van Moh F; Vetter J; Lai HH
Neurourol Urodyn; 2018 Nov; 37(8):2911-2918. PubMed ID: 30187950
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping of interstitial cystitis/bladder pain syndrome.
Akiyama Y; Hanno P
Int J Urol; 2019 Jun; 26 Suppl 1():17-19. PubMed ID: 31144756
[TBL] [Abstract][Full Text] [Related]
14. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
15. Using social media to crowdsource collection of urine samples during a national pandemic.
Ward EP; Bartolone SN; Sharma P; Chancellor MB; Lamb LE
Int Urol Nephrol; 2022 Mar; 54(3):493-498. PubMed ID: 35080680
[TBL] [Abstract][Full Text] [Related]
16. Small Fiber Polyneuropathy in Hunner Lesion and Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome.
Han E; Killinger KA; Turner KM; Gilleran J; Tenney D; Peters KM
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e91-e95. PubMed ID: 32217920
[TBL] [Abstract][Full Text] [Related]
17. Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships.
Homma Y
Int J Urol; 2019 Jun; 26 Suppl 1():20-24. PubMed ID: 31144731
[TBL] [Abstract][Full Text] [Related]
18. Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients.
Kamasako T; Kaga K; Inoue KI; Hariyama M; Yamanishi T
Int J Urol; 2022 May; 29(5):406-412. PubMed ID: 35102612
[TBL] [Abstract][Full Text] [Related]
19. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
[TBL] [Abstract][Full Text] [Related]
20. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
